Prostate Cancer News on BioPortfolio

ALS drug may help treat prostate cancer

Wiley Researchers have discovered a new use for an old drug as a potential treatment for prostate cancer. The findings are published in the journal The Prostate.

FDA Grants Rucaparib Breakthrough Designation for mCRPC

The FDA has granted the PARP inhibitor rucaparib a breakthrough therapy designation for singleagent use in adult patients with BRCA12positive metastatic castrationresistant prostate cancer following at least 1 androgen receptor–directed therapy a...